Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-human Tim-1 antibody with neutralization activity

An antibody and variable region technology, applied in the fields of genetic engineering and cellular immunology

Inactive Publication Date: 2019-01-25
ACADEMY OF MILITARY MEDICAL SCI
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Experimental studies have shown that blocking the function of Tim-1 can significantly inhibit the infection of the above viruses, but there is still no human Tim-1 neutralizing antibody on the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human Tim-1 antibody with neutralization activity
  • Anti-human Tim-1 antibody with neutralization activity
  • Anti-human Tim-1 antibody with neutralization activity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] Example 1 Screening Tim-1 Antibody

[0068] 1. Construction of phage antibody library

[0069]Extract mRNA from human lymphocytes, reverse transcribe it into cDNA, and use primers complementary to the conserved regions on both sides of the antibody variable region gene to amplify the heavy chain (VH) and The light chain (VL) gene is used to construct a library; the scFv single-chain antibody is expressed after being inserted into the phage vector, and the scFv is connected by an artificial linker between VH and VL.

[0070] 2. Screening of anti-human Tim-1 antibody

[0071] (1) The phages adhered to the human Tim-1-Fc protein, and the human Fc protein was used as a negative control, and the phages that bound to the Tim-1-Fc protein but not human Fc were retained.

[0072] (2) Repeated washing to remove non-specific binding, eluting and collecting the phage bound to Tim-1;

[0073] (3) Re-infect Escherichia coli to screen specific phage antibodies.

[0074] 3. PCR id...

Embodiment 2

[0080] Embodiment 2 Amplification of Monoclonal Antibody HF22

[0081] 1. Materials

[0082] Protein A Sepharose CL 4B column Protein column: product of Beijing Benyuan Zhengyang Biotechnology Co., Ltd.; pcDNA3.1 plasmid: Invitrogen; sources of other reagents and materials are the same as in Example 1.

[0083] 2. Methods and Results

[0084] (1) the monoclonal antibody HF22 light chain variable region gene obtained in Example 1, the light chain constant region gene is packed into pcDNA3.1 plasmid, and the carrier containing the monoclonal antibody HF22 light chain gene is obtained; the obtained embodiment 1 The heavy chain variable region gene of the monoclonal antibody HF22 and the heavy chain constant region gene are loaded into the pcDNA3.1 plasmid to obtain a vector containing the heavy chain gene of the monoclonal antibody HF22.

[0085] (2) Co-transfect the vector containing the light chain gene of the monoclonal antibody HF22 and the vector of the heavy chain gene in...

Embodiment 3

[0089] Example 3 Specific Detection of Tim-1 Protein of Monoclonal Antibody HF22

[0090] 1. Method

[0091] The specificity of monoclonal antibody HF22 was detected by ELISA.

[0092] (1) Coat 5 μg / ml human Tim-1 fusion protein in an ELISA plate, overnight at 4°C;

[0093] (2) Block unbound sites with skimmed milk powder, then wash 5 times with PBS buffer containing 0.2% Tween;

[0094] (3) Prepare different concentrations of anti-human Tim-1 antibody HF22 and control antibody, add to the ELISA strip in step (2), incubate at 37° C. for 1 hour, and wash 5 times with PBS buffer containing 0.2% Tween;

[0095] (4) Add HRP-labeled goat anti-human antibody, incubate at 37°C for 30 minutes, wash 5 times with PBS buffer containing 0.2% Tween; add TMB to develop color, and detect OD after 1mol / L sulfuric acid terminates 450 value.

[0096] 2. Results

[0097] The result is as figure 1 As shown, antibody HF22 can effectively bind Tim-1 antigen protein in a dose-dependent manner....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses anti-human Tim-1 antibody HF22 with neutralization activity. The antibody has amino acid sequences shown as SEQ ID NO.4 and SEQ ID NO.9. The invention also provides a nucleic acid molecule for encoding the antibody HF22, an expression vector containing the nucleic acid molecule and a host cell. The provided antibody is a whole humanized antibody and can be specifically combined with human Tim-1, so that the antibody can be used for diagnosing and treating diseases relevant to the Tim-1; meanwhile, the HF22 can obviously inhibit the virus infection, so that diseases caused by virus infection can be treated.

Description

technical field [0001] The present invention belongs to the fields of cellular immunology and genetic engineering, and relates to an anti-human Tim-1 antibody HF22 with neutralizing activity. Background technique [0002] Tim-1 (T cell immunoglobulin domain and mucin domain protein-1), also known as human hepatitis A virus receptor-1 (human hepatitis A virus receptor, hHAVcr-I) or kidney injury molecule-1 (kidney injury molecule 1, KIM-1), is the first molecule discovered in the Tim family gene. Tim-1 is expressed on CD4 + T cells begin to transcribe at the initial stage of antigen stimulation, provide co-stimulatory signals for T cell activation, participate in the proliferation and differentiation of T cells, and can inhibit the occurrence of peripheral tolerance. The Tim-1 gene encodes a type I transmembrane protein consisting of an N-terminal immunoglobulin V domain (IgV), a mucin-like domain, a transmembrane domain, and a cytoplasmic tail with a phosphorylation motif ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12N15/13A61K39/395A61P31/14A61P31/18G01N33/577G01N33/569
CPCA61P31/14A61P31/18C07K16/2803C07K2317/24C07K2317/565C07K2317/76G01N33/56983G01N33/56988G01N33/577G01N2333/70503Y02A50/30
Inventor 韩根成侯春梅肖鹤王仁喜陈国江李葛张艳玲窦帅杰冯健男沈倍奋
Owner ACADEMY OF MILITARY MEDICAL SCI